Physician
Appiagyei, Michael
Appiagyei, Michael was paid $5.14M by Medicaid between Jan 2018 and Dec 2024, across 63 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 38% of everything it billed.
33Billing provider infoAPPIAGYEI, MICHAEL
HOFFMAN ESTATES, IL 60169
HOFFMAN ESTATES, IL 60169
33aNPI1154390193assigned 03/14/2006
33bProvider typePediatrics Physician
28Total paid$5.14M
24GClaims118,903
24DCodes billed63
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Illinois
Rank by total paid#9 of 1,805
Median peer was paid$55K
This provider vs. median93×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,095 | $572K | |
| 2019 | 16,844 | $690K | |
| 2020 | 16,895 | $685K | |
| 2021 | 17,605 | $728K | |
| 2022 | 22,762 | $930K | |
| 2023 | 16,832 | $763K | |
| 2024incomplete | 13,870 | $769K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 38% | 29,228 | 23,126 | $1.93M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 23,671 | 18,454 | $1.11M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.9% | 3,779 | 3,082 | $305K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.7% | 4,047 | 3,216 | $293K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.3% | 3,004 | 2,298 | $223K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 4.1% | 1,467 | 1,161 | $209K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.6% | 1,955 | 1,452 | $131K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.8% | 5,803 | 4,703 | $92K |
| 87428 | 1.4% | 1,099 | 835 | $70K | |
| 90686 | 1.3% | 5,780 | 4,651 | $69K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.2% | 789 | 655 | $63K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.2% | 2,560 | 2,052 | $60K |
51 more codes
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.0% | 3,333 | $52K |
| 94664 | <1% | 3,580 | $46K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,279 | $45K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,065 | $43K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 460 | $35K |
| 99000 | <1% | 1,546 | $35K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,317 | $32K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 533 | $27K |
| 90670 | <1% | 1,377 | $27K | |
| 90734 | <1% | 1,394 | $24K | |
| 90620 | <1% | 1,310 | $24K | |
| 90649 | <1% | 1,814 | $23K | |
| 90651 | <1% | 283 | $20K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 687 | $17K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,481 | $12K |
| 90716 | <1% | 592 | $10K | |
| 99406 | <1% | 1,883 | $10K | |
| 94375 | <1% | 299 | $9K | |
| 90656 | <1% | 511 | $9K | |
| 90698 | <1% | 726 | $9K | |
| 0071A | <1% | 206 | $9K | |
| 90707 | <1% | 566 | $8K | |
| 0072A | <1% | 186 | $8K | |
| 90715 | <1% | 583 | $7K | |
| 90633 | <1% | 537 | $6K | |
| 90619 | <1% | 307 | $5K | |
| 90677 | <1% | 105 | $5K | |
| 90744 | <1% | 311 | $3K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 122 | $3K |
| 99336 | <1% | 123 | $2K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 1,452 | $2K |
| 95930 | <1% | 37 | $2K | |
| 99384 | <1% | 18 | $1K | |
| G0008 | Administration of influenza virus vaccine | <1% | 194 | $1K |
| 90688 | <1% | 59 | $1K | |
| 90696 | <1% | 46 | $975.58 | |
| 90648 | <1% | 117 | $975.44 | |
| 90685 | <1% | 110 | $959.56 | |
| 90700 | <1% | 107 | $670.84 | |
| 90723 | <1% | 33 | $666.50 | |
| 93000 | <1% | 14 | $188.21 | |
| 91307 | <1% | 184 | $187.50 | |
| 99490 | Ccm add 20min | <1% | 38 | $161.10 |
| 90681 | <1% | 16 | $102.40 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 3,247 | $13.75 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 208 | $6.41 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 13 | $0.00 |
| 90461 | 0% | 1,270 | $0.00 | |
| 82947 | 0% | 13 | $0.00 | |
| 99072 | 0% | 14 | $0.00 | |
| Q2038 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.